NCT06037109 - VIDAS® NEPHROCLEAR Reference Interval Study | Biotech Hunter

Enrollment

585

Participants

Timeline

Start Date

July 18, 2023

Primary Completion Date

December 28, 2023

Study Completion Date

December 28, 2023

Conditions

Healthy

Interventions

DEVICE

Diagnostic Test: VIDAS® NEPHROCLEAR™ CCL14 Test

Previously collected urine samples will be tested using the VIDAS® NEPHROCLEAR™ CCL14 Test

Trial Locations (2)

George Washington University, Washington D.C.

University of Illinois Chicago, Chicago